{
    "status": "accepted",
    "chain_of_thought": "[Article Type: Case Report] In this article, I found the following liver injury-related lab values and clinical outcomes: The patient is a 69-year-old male with atrial fibrillation who developed acute hepatitis after starting dabigatran. Lab results from the case presentation show peak ALT of 1064 U/L, AST of 589 U/L, ALP of 109 IU/L on 26 November 2024, and improvement after discontinuation. Bilirubin levels are mentioned in Figure 2 but specific peak values are not provided in the text. INR, GGT, and Albumin are not mentioned. The clinical outcome is improved/discharged as the patient was discharged on 11 December 2024 with normalized liver function and switched to edoxaban.",
    "patient_age": "69",
    "patient_gender": "Male",
    "suspected_drug": "dabigatran",
    "lab_results": {
        "ALT": "1064 U/L",
        "AST": "589 U/L",
        "ALP": "109 IU/L",
        "GGT": null,
        "Bilirubin": null,
        "INR": null,
        "Albumin": null
    },
    "clinical_outcome": "Improved/Discharged",
    "AI_confidence_score": 0.85
}